{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:13:40Z","timestamp":1791198820772,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1038\/bjc.2011.455","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T21:08:03Z","timestamp":1320181683000},"page":"1818-1824","source":"Crossref","is-referenced-by-count":64,"title":["Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers"],"prefix":"10.1038","volume":"105","author":[{"given":"E-I","family":"Braicu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Pietzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Denkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Fotopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"issue":"6","key":"BFbjc2011455_CR1","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/cncr.24915","volume":"116","author":"A Bamias","year":"2010","unstructured":"Bamias A, Psaltopoulou T, Sotiropoulou M, Haidopoulos D, Lianos E, Bournakis E, Papadimitriou C, Rodolakis A, Vlahos G, Dimopoulos MA (2010) Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy. Cancer 116 (6): 1462\u20131468","journal-title":"Cancer"},{"issue":"Suppl 2","key":"BFbjc2011455_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/modpathol.3800306","volume":"18","author":"DA Bell","year":"2005","unstructured":"Bell DA (2005) Origins and molecular pathology of ovarian cancer. Mod Pathol 18 (Suppl 2): 19\u201332","journal-title":"Mod Pathol"},{"key":"BFbjc2011455_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2217\/14796694.4.3.403","volume":"4","author":"S Blagden","year":"2008","unstructured":"Blagden S, Gabra H (2008) Future directions in the management of epithelial ovarian cancer. Future Oncol 4: 403\u2013411","journal-title":"Future Oncol"},{"issue":"5","key":"BFbjc2011455_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/CCO.0b013e32832eab1f","volume":"21","author":"S Blagden","year":"2009","unstructured":"Blagden S, Gabra H (2009) Promising molecular targets in ovarian cancer. Curr Opin Oncol 21 (5): 412\u2013419","journal-title":"Curr Opin Oncol"},{"key":"BFbjc2011455_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ygyno.2004.07.045","volume":"95","author":"GH Eltabbakha","year":"2004","unstructured":"Eltabbakha GH, Mountb SL, Beattyb B, Simmons-Arnoldb L, Cooperb K, Morgan A (2004) Factors associated with cytoreducibility among women with ovarian carcinoma. Gynecol Oncol 95: 377\u2013383","journal-title":"Gynecol Oncol"},{"issue":"12","key":"BFbjc2011455_CR6","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.ejso.2010.09.008","volume":"36","author":"C Fotopoulou","year":"2010","unstructured":"Fotopoulou C, Richter R, Braicu EI, Schmidt SC, Lichtenegger W, Sehouli J (2010) Can complete tumour resection be predicted in advanced primary epithelial ovarian cancer? A systematic evaluation of 360 consecutive patients. Eur J Surg Oncol 36 (12): 1202\u20131210","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"BFbjc2011455_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1245\/s10434-010-1245-3","volume":"18","author":"C Fotopoulou","year":"2011","unstructured":"Fotopoulou C, Richter R, Braicu IE, Schmidt SC, Neuhaus P, Lichtenegger W, Sehouli J (2011) Clinical outcome of tertiary surgical cytoreduction in patients with recurrent epithelial ovarian cancer. Ann Surg Oncol 18 (1): 49\u201357","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"BFbjc2011455_CR8","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/cncr.24926","volume":"116","author":"DM Gershenson","year":"2010","unstructured":"Gershenson DM (2010) The heterogeneity of epithelial ovarian cancer: getting it right. Cancer 116 (6): 1400\u20131402","journal-title":"Cancer"},{"issue":"1","key":"BFbjc2011455_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ygyno.2009.03.001","volume":"114","author":"DM Gershenson","year":"2009","unstructured":"Gershenson DM, Sun CC, Bodurka D, Coleman RL, Lu KH, Sood AK, Deavers M, Malpica AL, Kavanagh JJ (2009) Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant. Gynecol Oncol 114 (1): 48\u201352","journal-title":"Gynecol Oncol"},{"issue":"3","key":"BFbjc2011455_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1006\/gyno.1996.0065","volume":"60","author":"BA Goff","year":"1996","unstructured":"Goff BA, Sainz de la Cuesta R, Muntz HG, Fleischhacker D, Ek M, Rice LW, Nikrui N, Tamimi HK, Cain JM, Greer BE, Fuller Jr AF (1996) Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 60 (3): 412\u2013417","journal-title":"Gynecol Oncol"},{"issue":"1","key":"BFbjc2011455_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.ygyno.2004.04.004","volume":"94","author":"CM Ho","year":"2004","unstructured":"Ho CM, Huang YJ, Chen TC, Huang SH, Liu FS, Chang Chien CC, Yu MH, Mao TL, Wang TY, Hsieh CY (2004) Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Gynecol Oncol 94 (1): 197\u2013203","journal-title":"Gynecol Oncol"},{"key":"BFbjc2011455_CR12","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0002-9378(87)90261-4","volume":"156","author":"International Federation of Gynecology and Obstetrics","year":"1987","unstructured":"International Federation of Gynecology and Obstetrics (1987) Changing in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 156: 263\u2013264","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"BFbjc2011455_CR13","first-page":"151","volume":"27","author":"RJ Kurman","year":"2008","unstructured":"Kurman RJ, Shih IeM (2008) Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27 (2): 151\u2013160","journal-title":"Int J Gynecol Pathol"},{"issue":"3","key":"BFbjc2011455_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, Shih IeM (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34 (3): 433\u2013443","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"BFbjc2011455_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ajog.2008.01.005","volume":"198","author":"RJ Kurman","year":"2008","unstructured":"Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih IeM (2008) Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol 198 (4): 351\u2013356","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"BFbjc2011455_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ygyno.2004.12.056","volume":"97","author":"D Pectasides","year":"2005","unstructured":"Pectasides D, Fountzilas G, Aravantinos G, Kalofonos HP, Efstathiou E, Salamalekis E, Farmakis D, Skarlos D, Briasoulis E, Economopoulos T, Dimopoulos MA (2005) Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience. Gynecol Oncol 97 (2): 436\u2013441","journal-title":"Gynecol Oncol"},{"issue":"3\u20134","key":"BFbjc2011455_CR17","first-page":"129","volume":"125","author":"J Sehouli","year":"2003","unstructured":"Sehouli J, K\u00f6nsgen D, Mustea A, Oskay-Ozcelik G, Katsares I, Weidemann H, Lichtenegger W (2003) [\u2018IMO\u2019- intraoperative mapping of ovarian cancer]. Zentralbl Gynakol 125 (3\u20134): 129\u2013135","journal-title":"Zentralbl Gynakol"},{"issue":"6","key":"BFbjc2011455_CR18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/jso.21652","volume":"102","author":"J Sehouli","year":"2010","unstructured":"Sehouli J, Richter R, Braicu EI, B\u00fchling KJ, Bahra M, Neuhaus P, Lichtenegger W, Fotopoulou C (2010a) Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients. J Surg Oncol 102 (6): 656\u2013662","journal-title":"J Surg Oncol"},{"issue":"8","key":"BFbjc2011455_CR19","first-page":"1331","volume":"20","author":"J Sehouli","year":"2010","unstructured":"Sehouli J, Savvatis K, Braicu EI, Schmidt SC, Lichtenegger W, Fotopoulou C (2010b) Primary versus interval debulking surgery in advanced ovarian cancer: results from a systematic single-center analysis. Int J Gynecol Cancer 20 (8): 1331\u20131340","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"BFbjc2011455_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jso.21288","volume":"99","author":"J Sehouli","year":"2009","unstructured":"Sehouli J, Senyuva F, Fotopoulou C, Neumann U, Denkert C, Werner L, G\u00fclten OO (2009) Intra-abdominal tumour dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer. J Surg Oncol 99 (7): 424\u2013427","journal-title":"J Surg Oncol"},{"issue":"5","key":"BFbjc2011455_CR21","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"164","author":"IeM Shih","year":"2004","unstructured":"Shih IeM, Kurman RJ (2004) Ovarian tumourigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164 (5): 1511\u20131518","journal-title":"Am J Pathol"},{"issue":"20","key":"BFbjc2011455_CR22","doi-asserted-by":"publisher","first-page":"7273","DOI":"10.1158\/1078-0432.CCR-05-0755","volume":"11","author":"IeM Shih","year":"2005","unstructured":"Shih IeM, Kurman RJ (2005) Molecular pathogenesis of ovarian borderline tumours: new insights and old challenges. Clin Cancer Res 11 (20): 7273\u20137279","journal-title":"Clin Cancer Res"},{"key":"BFbjc2011455_CR23","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0002-9440(10)62549-7","volume":"160","author":"G Singer","year":"2002","unstructured":"Singer G, Kurman RJ, Chang H-W, Cho SKR, Shih I-M (2002) Diverse tumourigenic pathways in ovarian serous carcinoma. Am J Pathol 160: 1223\u20131228","journal-title":"Am J Pathol"},{"issue":"5","key":"BFbjc2011455_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","volume":"16","author":"R Vang","year":"2009","unstructured":"Vang R, Shih IeM, Kurman RJ (2009) Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol 16 (5): 267\u2013282","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"BFbjc2011455_CR25","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1245\/s10434-010-0964-9","volume":"17","author":"P Wimberger","year":"2010","unstructured":"Wimberger P, Wehling M, Lehmann N, Kimmig R, Schmalfeldt B, Burges A, Harter P, Pfisterer J, du Bois A (2010) Influence of residual tumour on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group). Ann Surg Oncol 17 (6): 1642\u20131648","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"BFbjc2011455_CR26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/cncr.25460","volume":"117","author":"RJ Zaino","year":"2010","unstructured":"Zaino RJ, Brady MF, Lele SM, Michael H, Greer B, Bookman MA (2010) Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal: a Gynecologic Oncology Group study. Cancer 117 (3): 554\u2013562","journal-title":"Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2011455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011455","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:04:43Z","timestamp":1684415083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2011455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["BFbjc2011455"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2011.455","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,1]]}}}